Search results
The Zacks Analyst Blog Highlights Abbott Laboratories, BP, Gilead Sciences, Smith-Midland and...
Zacks via Yahoo Finance Canada· 1 month agoFor Immediate Release Chicago, IL – June 24, 2024 – Zacks.com announces the list of stocks featured...
Top Analyst Reports for AstraZeneca, QUALCOMM & FedEx
Zacks via Yahoo Finance Canada· 3 months agoToday's Research Daily features new research reports on 16 major stocks, including AstraZeneca PLC...
20 Fastest Growing Biotech Companies in the US
Insider Monkey via Yahoo Finance Canada· 5 months agoIn this article, we will be taking a look at the 20 fastest growing biotech companies in the US. If you are not interested in learning about the...
Gilead to buy CymaBay for $4.3 billion in bets on liver disease treatment
Reuters via Yahoo Finance Canada· 6 months ago(Reuters) -Gilead Sciences has agreed to buy CymaBay Therapeutics for $4.3 billion, gaining access...
13 Most Profitable Pharmaceutical Stocks Now
Insider Monkey via Yahoo Finance Canada· 7 months agoIn this article, we discuss the 13 most profitable pharmaceutical stocks to buy. You can skip our detailed analysis of the pharmaceutical sector and its...
There's A Real Chance To Stop This Miserable, Fatal Infection
HuffPost via Yahoo Canada News· 8 months agoDying from hepatitis C is a notoriously miserable way to go. The virus attacks your liver ― in many...
15 Best Drug Stocks To Invest In
Insider Monkey via Yahoo Finance Canada· 8 months agoIn this article, we discuss the 15 best drug stocks to invest in. You can skip our detailed analysis of the drug and pharmaceutical sector and its...
Jim Simons Stock Portfolio: 12 Biggest Healthcare Stocks
Insider Monkey via Yahoo Finance Canada· 9 months agoIn this piece, we will take a look at the 12 biggest healthcare stocks in Jim Simons’ stock...
Gilead's (GILD) Veklury Gets CHMP Nod in Damaged Liver Patients
Zacks via Yahoo Finance Canada· 10 months agoGilead's (GILD) Veklury gets a positive CHMP opinion, recommending the use of the drug to treat...
UPDATE 1-Gilead Sciences prevails in US government lawsuit over HIV drug patents
Reuters via Yahoo Finance Canada· 1 year agoA federal jury on Tuesday found that Gilead Sciences Inc did not infringe U.S. patents with its HIV-prevention regimens using the drugs Truvada and Descovy, handing the government a defeat in ...
